Rudi Balling is the Director of the Luxembourg Centre for Systems Biomedicine in Luxembourg. He is a developmental biologist and geneticist. He studied nutrition at the Universities of Bonn and Washington State University, USA and received his PhD in Human Nutrition from the University of Aachen, Germany. After completing research posts at the Samuel Lunenfeld Research Institute in Toronto, Göttingen and Freiburg, he became director of the Institute of Mammalian Genetics at the GSF in Munich (1993-2000) and of the Helmholtz Centre of Infection Research in Braunschweig (2001-2009). During this time Rudi Balling has coordinated the German Human Genome Project (1996-2000), the European ESFRI-Project EATRIS (European Advanced Translational Medicine Research Infrastructure) (2008-2010) and the Bill & Melinda Gates Grand Challenges Consortium on the development of Vaccine Animal Models (2005-2009). In 2009, he founded the Luxembourg Centre for Systems Biomedicine (LCSB), an interdisciplinary Research Centre at the University of Luxembourg dedicated to the analysis of neurodegenerative diseases through computational and system biology oriented approaches. Rudi Balling is member of several Scientific Advisory Boards, amongst others the Excellence Cluster „Inflammation at Interfaces“ at the University of Kiel (since 2013, elected chairman since 2014), the RIKEN Center for Integrative Medical Sciences Advisory Council (since 2013) and the Institute of Molecular Genetics (IMG), Academy of Sciences of the Czech Republic (since 2013).